ViroVet is a pioneering company dedicated to the development of disruptive and innovative technologies for the control of viral diseases in livestock, with antiviral drugs (video) for respiratory disease complexes and innovative vaccines (video) for viral infections in swine leading the pipeline. 

Biotechnology

Pharmaceutical

Veterinary & Pet

Virovet

Virovet's headquarters in Leuven, Belgium

Erwin Blomsma

Bart Crijns

Stefaan Wera

Nesya Goris

Ilse Sienaert

Laetitia Gerbe

George Gunn

Ludwig Goris

Patrik Haesen

Yannick Vancoppenolle

Thomas Beke

The Directors team at ViroVet oversees strategic decision-making, financial management, and directs specialized research and development in molecular biology, medicinal chemistry, and vaccines. They ensure alignment with the company's objectives to innovate and advance antiviral drugs and vaccines for livestock viral diseases.

Directors

The Research and Development team at ViroVet focuses on creating groundbreaking antiviral drugs and vaccines for combating viral diseases in livestock. The team, composed of experienced scientists and senior research associates, conducts cutting-edge research, develops new methodologies, and tests innovative products to advance the company's mission of controlling viral infections in animals.

Research and Development

The Leadership Team at ViroVet is responsible for driving the strategic vision and direction of the company, overseeing the development and implementation of innovative technologies for viral disease control in livestock. Comprising the CEO, CDO, and COO, this team collaborates to ensure alignment across all departments, fosters partnerships, and secures resources to advance ViroVet's mission of revolutionizing animal health through cutting-edge antiviral drugs and vaccines.

Virovet

Org chart

Board & advisors

Teams

Directors

Research and Development

Leadership Team

Offices

Virovet

Org chart

Board & advisors

Teams

Directors

Research and Development

Leadership Team

Offices

Related companies